IDEAL MANAGER – DURING THE TIMES OF INTENSE CHANGE
Adizes’ Seminar
December 10, 2007. Vrsac, Serbia

The company Hemofarm from Vrsac, Serbia is organizing a one-day seminar with Dr. Ichak Adizes. The seminar will be held at the Congress Hal of the Millennium Center in Vrsac, on December 10, 2007. The expected number of participants to this seminar is 500 successful and CEOs and managers of the large Serbian companies.

Lecturers:

Dr. Ichak Adizes, founder and CEO of the Adizes Institute;
Zvezdan Horvat, Senior Associate of the Adizes Institute, Director & Partner ASEE;
Boris Vukic,  Senior Associate of the Adizes Institute, Marketing Director & Partner ASEE

The seminar will cover the following issues:

• How to run a company during the times of intense changes
• Complex task for the managers and entrepreneurs of the large companies
• Get to the mission by using a proper selection and tools

Learn more about this seminar: http://www.hemofarmlogica.com/home.aspx
Info: www.hemofarmlogica.com
Contact: Vladan Majstorovic +381 13 800 336 f. 800 316; vmajstorovic@centarmillennium.co.yu

HEMOFARM, Vrsac, Serbia
Hemofarm was established in 1960. Pursuant to the decision of the Shareholders’ Assembly of November 10, 2006, Hemofarm a.d. was transferred into a closed joint-stock company.

Hemofarm is one of the best working companies in Serbia and among the first companies in the area that started to value corporate social responsibility at the time when even such a term was not in use. It therefore came as no surprise among other professionals that Hemofarm received the Corporate Philanthropy Excellence Award VIRTUS in the crowded central hall of the National Assembly of the Republic of Serbia on November 20, 2007 for its long standing partnership between the business and non-profit sector. The purpose of this prestigious award is to recognize and publicly emphasize the companies and enterprises which, due to their material and financial support give the best examples to others and set up standards which others should strive for in the world of responsible business.

Production and sales of medical products represent the core activities successfully performed by Hemofarm for five decades already. Capital, knowledge, competence and energy have been woven in the construction of production complex. Hemofarm has achieved technological completeness. It has met the high standards of the industry in regard to the production of medicinal products. The plants have been adjusted to the current GMP requirements while the European certificates guarantee the highest level of products quality.

All forms of medical products are produced in Hemofarm’s factories starting from the simple ones to effervescent, pellet and Mi-O-Vial injectable forms. Medicinal product range includes almost all pharmacotherapeutical forms. By the end of the last century Hemofarm won the leading position in the domestic market through its quality and good business policy, and it is also the greatest Serbian exporter of medicinal products. The third of the overall production is exported to the markets of Russia, neighbouring countries, EU, developed countries of Africa and Middle East.

Developing its core business, Hemofarm started to establish the companies and marketing stations in 1991, so today it is present in Timisoara, Bucharest, Skopje, Ljubljana, Banjaluka, Sarajevo, Bad Homburg, Moscow, Kiev, Obninsk, Beijing, Baghdad and Washington.

The application of the state-of-the-art technology, compliance with the international standards and regulations and highly skilled personnel represent the guarantee of Hemofarm’s products quality. Hemofarm’s production is performed in the most up-to-date plants in Vršac, Dubovac, Podgorica, Šabac, Banjaluka and since recently in the Russian city Obninsk as well.

Although Hemofarm recorded an increase its activities over the course of the closing decade of the last century, pharmaceutical production has always been, and still remains, its core activity. Five companies out of all companies operating within Hemofarm Group, deal with the development, production and sales of medicinal products.
Hemofarm’s strategic development is focused on the core business, i.e. development, production and sale of drugs, which means that it will dispose of all non-core businesses.
Being the major pharmaceutical company in the country which makes an important part of the healthcare system, Hemofarm has a great responsibility towards the population’s health. Constant efforts to provide patients with contemporary and efficient medicamental therapies, in cooperation with healthcare workers, while frequently neglecting economic logics, show its essential dedication to the population with damaged health.